Areas of Focus

  • Diabetic Foot Ulcers (DFUs)
  • Venous Leg Ulcers (VLUs)
  • Peripheral Arterial Disease (PAD)/Neuroischemic Ulcers
  • Peripheral Neuropathy
  • Plantar Fasciitis
  • Bunions
  • Vascular Pathology
  • Onychomycosis
  • Achille’s Tendonitis

LPP Wound and Clinical Research Overview

Our LPP Wound and Clinical Research facility is a free-standing wound care and clinical research center dedicated to the advancement of lower extremity wound management. We offer traditional wound care services without hospital-based facility fees in addition to Phase I-IV clinical research trials in the field of chronic non-healing wounds. Our focus is patient and wound-centric, focusing on drug and medical device studies that show promise in the field of chronic wound healing.

LPP Wound and Research has one facility in Fresno California. Our facility at Valley Podiatry & Diabetic Foot Center is situated approximately 7 miles north of Downtown Fresno. It is equipped to handle studies of any complexity for leading pharmaceutical and medical device companies. We are close to the I-41 freeway with easy access and parking for patients and research participants.

We pride ourselves on our excellent record of exceeding the industry’s need for sites that can facilitate rapid study start-up, patient enrollment, efficient execution, patient safety, patient retention, and completion of the studies in a safe environment.

Our Vision
Unrestricted patient access to chronic wound management.

Mission Statement
LPP Research is a clinical research center dedicated to attracting, nurturing and retaining patients/research participants and staff to accomplish outstanding chronic wound care and Phase I-IV studies. Our patients, participants, sponsors, partners and staff enjoy working together in an environment of mutual respect that fosters personal growth and optimal health. We passionately believe that freestanding wound care and clinical research studies can make a difference to the many that suffer from chronic non healing wounds. We strive to be the best at what we do and at all times be meticulous in all our practices placing the care, safety and confidentiality of our patients and research participants first.

Experience You Can Trust

With more than 30 years of combined wound care and clinical research experience, LPP Wound and Research management, clinical teams and staff have dedicated their efforts to the advancement of the chronic non healing wound via freestanding facilities directed at both the management of chronic wounds and Phase I-IV chronic wound clinical trials for many of the world’s leading pharmaceutical and biotech companies. We have extensive device and product experience, ranging from topical administration to cell-based therapy, culminating in pivotal trials for FDA submission. We have special expertise in managing the freestanding wound facility and conducting Phase I-IV clinical research. All patients are offered the latest treatment options in both the freestanding wound facility, and clinical research arm under strict guidelines from the Food and Drug Administration. Patients and clinical research participants experience advanced wound management leading to improved outcome measures. At all times, safety and confidentiality are guarded with the utmost concern. Of note, LPP Wound and Research providers speak, author, and consult internationally.

Patient Demographics

LPP Wound and Research facilities carry out cutting-edge advanced wound management and clinical trials using medications and medical devices developed by the pharmaceutical and biotech industries. We are situated in a highly populated region of the central valley of California with recruitment from a geographically diverse population. The greater Fresno population exceeds 1,000,000. Our staff works with the local communities and health centers, diabetes educators and physicians offices in Fresno and surrounding counties. Wound care patients and research participants in clinical trials at our sites come from a variety of different sources and we advertise regularly in the local media, radio and TV. LPP Wound and Research participates in health fairs, symposiums and other community events annually.

An estimated 550 million people will be diagnosed worldwide by 2030.
Diabetes is a worldwide catastrophe currently affecting approximately 29 million people in the United States.
An individual suffering from diabetes has a 1-in-4 chance of developing a wound over the course of their lifetime.
Greater than 50% of all wounds become infected and approximately 20% of all infected wounds of the lower extremity lead to amputation.
There are currently 6.5 million patients in the United States who require wound care on a regular basis.